Showing results (291-300 of 319) with videos related to
Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|July 12, 2008
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancerGiuseppe Perrone, Pier Adelchi Ruffini, Vincenzo Catalano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapyAnnamaria Ruzzo, Francesco Graziano, Fotios Loupakis, et al.Free Radical Biology & Medicine|June 4, 2013
Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulationFabiola Olivieri, Raffaella Lazzarini, Lucia Babini, et al.Antibiotics (Basel, Switzerland)|April 23, 2022
Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in ItalyMarilena Agosta, Daniela Bencardino, Marta Argentieri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancerFrancesco Graziano, Annamaria Ruzzo, Fotios Loupakis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancerFotios Loupakis, Luca Pollina, Irene Stasi, et al.BMC Cancer|June 15, 2011
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancerFotios Loupakis, Annamaria Ruzzo, Lisa Salvatore, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicinClara Guerzoni, Valentina Fiori, Mario Terracciano, et al.Orphanet Journal of Rare Diseases|January 11, 2014
Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trialLuciana Chessa, Vincenzo Leuzzi, Alessandro Plebani, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 30, 2022
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein productionAlessandra Fraternale, Marta De Angelis, Riccardo De Santis, et al.Pageof 32